间隙连接蛋白43与肿瘤

doi:10.3760/cma.j.issn.1673-422X.2018.01.007

摘要/Abstract

摘要： 细胞间隙连接是一种特殊的蛋白质通道，间隙连接介导的细胞间信息交流对细胞生长、分化及组织稳态至关重要。间隙连接蛋白43（Cx43）是间隙连接蛋白家族成员之一，近年来研究发现Cx43基因表达异常易导致细胞间隙连接通讯功能缺陷，这与多种肿瘤的发生、转移及预后密切相关，Cx43有望成为肿瘤临床诊断和治疗的新靶点。

关键词: 连接蛋白43, 肿瘤, 细胞间通讯

Abstract: Cell gap junction is a special protein channel. Gap junctionmediated exchange of information between cells is crucial for cell growth, differentiation and tissue homeostasis. Connexin 43 (Cx43) is one of the members of the gap junction protein family. In recent years, researches show that abnormal Cx43 gene expression leads to the cell gap junctional communication dysfunction, which is closely related to the occurrence, metastasis and prognosis of a variety of tumors. Cx43 is expected to become a new target for clinical diagnosis and treatment of tumors.

Key words: Connexin 43, Neoplasms, Cell communication

文晓荣，莫红梅，郭涛，丁梦婷. 间隙连接蛋白43与肿瘤[J]. 国际肿瘤学杂志, 2018, 45(1): 32-.

Wen Xiaorong*, Mo Hongmei, Guo Tao, Ding Mengting. Connexin 43 and tumors[J]. Journal of International Oncology, 2018, 45(1): 32-.

参考文献

［1］ Grek CL, Rhett JM, Ghatnekar GS. Cardiac to cancer: connecting connexins to clinical opportunity［J］. FEBS Lett, 2014, 588(8): 13491364. DOI: 10.1016/j.febslet.2014.02.047. ［2］ Rhett JM, Fann SA, Yost MJ. Purinergic signaling in early inflammatory events of the foreign body response: modulating extracellular ATP as an enabling technology for engineered implants and tissues［J］. Tissue Eng Part B Rev, 2014, 20(5): 392402. DOI: 10.1089/ten.TEB.2013.0554. ［3］ Jin Z, Xu S, Yu H, et al. miR125b inhibits Connexin43 and promotes glioma growth［J］. Cell Mol Neurobiol, 2013, 33(8): 11431148. DOI: 10.1007/s1057101399801. ［4］ Ableser MJ, Penuela S, Lee J, et al. Connexin43 reduces melanoma growth within a keratinocyte microenvironment and during tumorigenesis in vivo［J］. J Biol Chem, 2014, 289(3): 15921603. DOI: 10.1074/jbc.M113.507228. ［5］ Chen R, Luan Y, Liu Z, et al. AR pathway is involved in the regulation of CX43 in prostate cancer［J］. Biomed Res Int, 2015, 2015: 514234. DOI: 10.1155/2015/514234. ［6］ Macdonald AI, Sun P, HernandezLopez H, et al. A functional interaction between the MAGUK protein hDIg and the gap junction protein connexin 43 in cervical tumour cells［J］. Biochem J, 2012, 446(1): 921. DOI: 10.1042/BJ20111144. ［7］ Sun P, Dong L, MacDonald AI, et al. HPV16 E6 controls the gap junction protein Cx43 in cervical tumour cells［J］. Viruses, 2015, 7(10): 52435256. DOI: 10.3390/v7102871. ［8］ Sulkowska U, Wincewicz A, KanczugaKoda L, et al. Eventual proapoptotic or antiapoptotic impact of aberrantly expressed Cx43 and Cx26 can depend on ERalpha overexpression in human endometrioid adenocarcinoma［J］. Gynecol Endocrinol, 2015, 31(8): 604608. DOI: 10.3109/09513590.2015.1017811. ［9］ Matharu G, Tucker O, Alderson D. Systematic review of intraperitoneal chemotherapy for gastric cancer［J］. Br J Surg, 2011, 98(9): 12251235. DOI: 10.1002/bjs.7586. ［10］ Tang B, Peng ZH, Yu PW, et al. Aberrant expression of Cx43 is associated with the peritoneal metastasis of gastric cancer and Cx43mediated gap junction enhances gastric cancer cell diapedesis from peritoneal mesothelium［J］. PLoS One, 2013, 8(9): e74527. DOI: 10.1371/journal.pone.0074527. ［11］ Fu Y, Shao ZM, He QZ, et al. HsamiRV206 represses the proliferation and invasion of breast cancer cells by targeting Cx43［J］. Eur Rev Med Pharmacol Sci, 2015, 19(11): 20912104. ［12］ Lamiche C, Clarhaut J, Strale PO, et al. The gap junction protein Cx43 is involved in the bonetargeted metastatic behaviour of human prostate cancer cells［J］. Clin Exp Metastasis, 2012, 29(2): 111122. DOI: 10.1007/s1058501194344. ［13］ Zhang A, Hitomi M, BarShain N, et al. Connexin 43 expression is associated with increased malignancy in prostate cancer cell lines and functions to promote migration［J］. Oncotarget, 2015, 6(13): 1164011651. DOI: 10.18632/oncotarget.3449. ［14］ Qiu X, Cheng JC, Zhao J, et al. Transforming growth factorβ stimulates human ovarian cancer cell migration by upregulating connexin43 expression via Smad2/3 signaling［J］. Cell Signal, 2015, 27(10): 19561962. DOI: 10.1016/j.cellsig.2015.07.010. ［15］ Liu X, Cao K, Xu C, et al. GATA3 augmentation downregulates Connexin43 in helicobacter pylori associated gastric carcinogenesis［J］. Cancer Biol Ther, 2015, 16(6): 987996. DOI: 10.1080/15384047.2015.1030552. ［16］ Ming J, Zhou Y, Du J, et al. miR381 suppresses C/EBPαdependent Cx43 expression in breast cancer cells［J］. Biosci Rep, 2015, 35(6). pii: e00266. DOI: 10.1042/BSR20150167. ［17］ Brockmeyer P, Hemmerlein B, Jung K, et al. Connexin subtype expression during oral carcinogenesis: a pilot study in patients with oral squamous cell carcinoma［J］. Mol Clin Oncol, 2016, 4(2): 298302. DOI: 10.3892/mco.2015.685. ［18］ Brockmeyer P, Jung K, Perske C, et al. Membrane connexin 43 acts as an independent prognostic marker in oral squamous cell carcinoma［J］. Int J Oncol, 2014, 45(1): 273281. DOI: 10.3892/ijo.2014.2394. ［19］ Ismail R, Rashid R, Andrabi K, et al. Pathological implications of Cx43 downregulation in human colon cancer［J］. Asian Pac J Cancer Prev, 2014, 15(7): 29872991. ［20］曹建, 孙萍. Ⅱ期结肠癌的辅助化学治疗［J］. 国际肿瘤学杂志, 2013, 40(6): 463465. DOI: 10.3760/cma. j.issn.1673422X.2013.06.020. ［21］ Wang J, Dai Y, Huang Y, et al. Alltrans retinoic acid restores gap junctional intercellular communication between oral cancer cells with upregulation of Cx32 and Cx43 expressions in vitro［J］. Med Oral Patol Oral Cir Bucal, 2013, 18(4): e569e577. ［22］ Forster T, Rausch V, Zhang Y, et al. Sulforaphane counteracts aggressiveness of pancreatic cancer driven by dysregulated Cx43mediated gap junctional intercellular communication［J］. Oncotarget, 2014, 5(6): 16211634. DOI: 10.18632/oncotarget.1764. ［23］ Grek CL, Rhett JM, Bruce JS, et al. Targeting connexin 43 with αconnexin carboxylterminal (ACT1) peptide enhances the activity of the targeted inhibitors, tamoxifen and lapatinib, in breast cancer: clinical implication for ACT1［J］. BMC Cancer, 2015, 15: 296. DOI: 10.1186/s1288501512296. ［24］ Ghosh S, Kumar A, Chandna S. Connexin43 downregulation in G2/M phase enriched tumour cells causes extensive lowdose hyperradiosensitivity (HRS) associated with mitochondrial apoptotic events［J］. Cancer Lett, 2015, 363(1): 4659. DOI: 10.1016/j.canlet.2015.03.046.

[1]	刘娜, 寇介丽, 杨枫, 刘桃桃, 李丹萍, 韩君蕊, 杨立洲. 血清miR-106b-5p、miR-760联合低剂量螺旋CT诊断早期肺癌的临床价值[J]. 国际肿瘤学杂志, 2024, 51(6): 321-325.
[2]	杨蜜, 别俊, 张加勇, 邓佳秀, 唐组阁, 卢俊. 局部晚期可切除食管癌新辅助治疗疗效及预后分析[J]. 国际肿瘤学杂志, 2024, 51(6): 332-337.
[3]	袁健, 黄燕华. Hp-IgG抗体联合血清DKK1、sB7-H3对早期胃癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(6): 338-343.
[4]	陈红健, 张素青. 血清miR-24-3p、H2AFX与肝癌患者临床病理特征及术后复发的关系研究[J]. 国际肿瘤学杂志, 2024, 51(6): 344-349.
[5]	郭泽浩, 张俊旺. PFDN及其亚基在肿瘤发生发展中的作用[J]. 国际肿瘤学杂志, 2024, 51(6): 350-353.
[6]	张百红, 岳红云. 新作用机制的抗肿瘤药物进展[J]. 国际肿瘤学杂志, 2024, 51(6): 354-358.
[7]	许凤琳, 吴刚. EBV在鼻咽癌肿瘤免疫微环境和免疫治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 359-363.
[8]	王盈, 刘楠, 郭兵. 抗体药物偶联物在转移性乳腺癌治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 364-369.
[9]	张蕊, 褚衍六. 基于FIT与肠道菌群的结直肠癌风险评估模型的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 370-375.
[10]	高凡, 王萍, 杜超, 褚衍六. 肠道菌群与结直肠癌非手术治疗的相关研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 376-381.
[11]	王丽, 刘志华, 杨伟洪, 蒋凤莲, 李全泳, 宋浩杰, 鞠文东. ROS1突变肺腺鳞癌合并脑梗死为主要表现的Trousseau综合征1例[J]. 国际肿瘤学杂志, 2024, 51(6): 382-384.
[12]	刘静, 刘芹, 黄梅. 基于SMOTE算法的食管癌放化疗患者肺部感染的预后模型构建[J]. 国际肿瘤学杂志, 2024, 51(5): 267-273.
[13]	杨琳, 路宁, 温华, 张明鑫, 朱琳. 炎症负荷指数与胃癌临床关系研究[J]. 国际肿瘤学杂志, 2024, 51(5): 274-279.
[14]	王俊毅, 洪楷彬, 纪荣佳, 陈大朝. 癌结节对结直肠癌根治性切除术后肝转移的影响[J]. 国际肿瘤学杂志, 2024, 51(5): 280-285.
[15]	张宁宁, 杨哲, 檀丽梅, 李振宁, 王迪, 魏永志. 宫颈细胞DNA倍体分析联合B7-H4和PKCδ对宫颈癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(5): 286-291.